Switch theme
Sign up to access all valuation multiples
ADDvise Group AB e is an international life science company. Operating a decentralized ownership model, in which company develop and acquire high quality companies within the business areas Lab and Healthcare.
1989
641
LTM Revenue n/a
LTM EBITDA n/a
$195M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
ADDvise Group has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, ADDvise Group achieved revenue of $172M and an EBITDA of $40.3M.
ADDvise Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See ADDvise Group valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $141M | $172M | XXX | XXX | XXX |
| Gross Profit | $59.3M | $92.7M | XXX | XXX | XXX |
| Gross Margin | 42% | 54% | XXX | XXX | XXX |
| EBITDA | $38.1M | $40.3M | XXX | XXX | XXX |
| EBITDA Margin | 27% | 23% | XXX | XXX | XXX |
| Net Profit | $8.4M | $10.7M | XXX | XXX | XXX |
| Net Margin | 6% | 6% | XXX | XXX | XXX |
| Net Debt | $60.8M | $117M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, ADDvise Group's stock price is SEK 1 (or $0).
ADDvise Group has current market cap of SEK 441M (or $45.4M), and EV of SEK 1.9B (or $195M).
See ADDvise Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $195M | $45.4M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, ADDvise Group has market cap of $45.4M and EV of $195M.
ADDvise Group's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate ADDvise Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for ADDvise Group and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $195M | XXX | XXX | XXX |
| EV/Revenue | 1.1x | XXX | XXX | XXX |
| EV/EBITDA | 4.8x | XXX | XXX | XXX |
| P/E | 4.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 141.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialADDvise Group's NTM/LTM revenue growth is n/a
ADDvise Group's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged n/a for the same period.
Over next 12 months, ADDvise Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate ADDvise Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for ADDvise Group and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 22% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ADDvise Group acquired XXX companies to date.
Last acquisition by ADDvise Group was XXXXXXXX, XXXXX XXXXX XXXXXX . ADDvise Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was ADDvise Group founded? | ADDvise Group was founded in 1989. |
| Where is ADDvise Group headquartered? | ADDvise Group is headquartered in Sweden. |
| How many employees does ADDvise Group have? | As of today, ADDvise Group has 641 employees. |
| Who is the CEO of ADDvise Group? | ADDvise Group's CEO is Mr. Rikard Akhtarzand. |
| Is ADDvise Group publicy listed? | Yes, ADDvise Group is a public company listed on STO. |
| What is the stock symbol of ADDvise Group? | ADDvise Group trades under ADDV A ticker. |
| When did ADDvise Group go public? | ADDvise Group went public in 1998. |
| Who are competitors of ADDvise Group? | Similar companies to ADDvise Group include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of ADDvise Group? | ADDvise Group's current market cap is $45.4M |
| What is the current revenue growth of ADDvise Group? | ADDvise Group revenue growth between 2023 and 2024 was 22%. |
| Is ADDvise Group profitable? | Yes, ADDvise Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
